Pharmacogenetics Research Network Interest Groups
(as of December 11, 2002)

• Resource and Expertise Groups
  • Haplotyping, Genotyping, Comparative Genomics
  • Population Genetics, Study Design, Statistics
  • Tissue Resources, Study Populations
  • Phenotyping Technologies/Pharmacokinetics
• Disease Focus Groups
  • Cancer
  • Cardiovascular-Pulmonary Signaling Systems
  • Adverse Drug Reactions
• Interest Groups Coordination

Resource & Expertise Groups

Haplotyping, Genotyping, Comparative Genomics

Leaders:

Anna DiRienzo, Ph.D., University of Chicago William Evans, Pharm.D., St. Jude Children’s Research Hospital

Population Genetics, Study Design, Statistics

Leaders:

Michael Province, Ph.D., Washington University Nicholas Schork, Ph.D., University of California, San Diego

Tissue Resources, Study Populations

Leaders:

Mark Watson, Ph.D., Washington University Catherine Schaefer, Ph.D., Kaiser Permanente

Phenotyping Technologies/Pharmacokinetics

Leaders:

Richard Weinshilboum, M.D., Mayo Foundation Erin Schuetz, Ph.D., St. Jude Children’s Research Hospital Dawood Darber, M.D., Vanderbilt University Richard Kim, M.D., Vanderbilt University

---

Disease Focus Groups

Cancer

Leaders:

Howard McLeod, Pharm. D., Washington University Deanna Kroetz, Ph.D., University of California, San Francisco

Cardiovascular-Pulmonary Signaling Systems

Leaders:

Ronald Krauss, M.D., Lawrence Berkeley National Laboratory Stephen Liggett, M.D., University of Cincinnati Daniel O’Connor, M.D., University of California, San Diego

Adverse Drug Reactions

Leaders:

Kathleen Giacomini, Ph.D., University of California, San Francisco Dan Roden, M.D., Vanderbilt University

---

Interest Groups Coordination

Leaders:

Mary Relling, Pharm.D., St. Jude Children’s Research Hospital Jerome Rotter, M.D., Cedars-Sinai Health System